These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29373815)

  • 1. Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).
    Deshpande GP; Imamdin A; Lecour S; Opie LH
    Life Sci; 2018 Mar; 196():127-132. PubMed ID: 29373815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.
    Kelly-Laubscher RF; King JC; Hacking D; Somers S; Hastie S; Stewart T; Imamdin A; Maarman G; Pedretti S; Lecour S
    Cardiovasc J Afr; 2014; 25(3):118-23. PubMed ID: 25000441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression.
    Feuerborn R; Becker S; Potì F; Nagel P; Brodde M; Schmidt H; Christoffersen C; Ceglarek U; Burkhardt R; Nofer JR
    Atherosclerosis; 2017 Feb; 257():29-37. PubMed ID: 28038379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.
    Karliner JS; Honbo N; Summers K; Gray MO; Goetzl EJ
    J Mol Cell Cardiol; 2001 Sep; 33(9):1713-7. PubMed ID: 11549349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective role of sphingosine-1-phosphate.
    Knapp M
    J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.
    Vessey DA; Li L; Kelley M; Zhang J; Karliner JS
    J Biochem Mol Toxicol; 2008; 22(2):113-8. PubMed ID: 18418901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.
    Vessey DA; Li L; Kelley M; Karliner JS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):425-9. PubMed ID: 18706887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells.
    Gurgui M; Broere R; Kalff JC; van Echten-Deckert G
    Cell Signal; 2010 Nov; 22(11):1727-33. PubMed ID: 20624458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanolamine is a novel STAT-3 dependent cardioprotective agent.
    Kelly RF; Lamont KT; Somers S; Hacking D; Lacerda L; Thomas P; Opie LH; Lecour S
    Basic Res Cardiol; 2010 Nov; 105(6):763-70. PubMed ID: 20938668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate attenuates hypoxia/reoxygenation-induced cardiomyocyte injury via a mitochondrial pathway.
    Ke M; Tang Q; Pan Z; Yin Y; Zhang L; Wen K
    Biochem Biophys Res Commun; 2019 Feb; 510(1):142-148. PubMed ID: 30661785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting sphingosine-1-phosphate signalling for cardioprotection.
    Kennedy S; Kane KA; Pyne NJ; Pyne S
    Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of melatonin, melatonin receptors and STAT3 in the cardioprotective effect of chronic and moderate consumption of red wine.
    Lamont K; Nduhirabandi F; Adam T; Thomas DP; Opie LH; Lecour S
    Biochem Biophys Res Commun; 2015 Oct; 465(4):719-24. PubMed ID: 26296463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.
    Zhao X; Ding EY; Yu OM; Xiang SY; Tan-Sah VP; Yung BS; Hedgpeth J; Neubig RR; Lau LF; Brown JH; Miyamoto S
    J Mol Cell Cardiol; 2014 Oct; 75():152-61. PubMed ID: 25106095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.
    Murakami A; Takasugi H; Ohnuma S; Koide Y; Sakurai A; Takeda S; Hasegawa T; Sasamori J; Konno T; Hayashi K; Watanabe Y; Mori K; Sato Y; Takahashi A; Mochizuki N; Takakura N
    Mol Pharmacol; 2010 Apr; 77(4):704-13. PubMed ID: 20097776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.